| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/07/2001 | CA2045883C Process for the extrusion preparation of actives granules |
| 08/04/2001 | CA2298041A1 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 08/03/2001 | CA2334066A1 A non-arrhythmogenic metabolite of oxybutynin |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001055360A1 Slow release protein polymers |
| 08/02/2001 | WO2001055220A1 Chitosan condensation products, their preparation and their uses |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001055092A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 08/02/2001 | WO2001054748A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
| 08/02/2001 | WO2001054744A1 Transdermal thermal polymerization |
| 08/02/2001 | WO2001054742A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054741A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054721A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | WO2001054710A1 Auxiliary agents for ophthalmic operation |
| 08/02/2001 | WO2001054709A1 Vzv orf29p protein-related compositions and methods |
| 08/02/2001 | WO2001054704A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 08/02/2001 | WO2001054687A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| 08/02/2001 | WO2001054685A1 Mucin synthesis inhibitors |
| 08/02/2001 | WO2001054684A1 Eye drops |
| 08/02/2001 | WO2001054683A1 Ibuprofen containing active agent preparation |
| 08/02/2001 | WO2001054675A2 Pharmaceutical compositions comprising terbinafine |
| 08/02/2001 | WO2001054674A1 Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups |
| 08/02/2001 | WO2001054673A1 Method for preparing and administering medicinal plant material |
| 08/02/2001 | WO2001054672A2 Closure of bacterial ghosts |
| 08/02/2001 | WO2001054671A1 Sustained-release preparation and process for producing the same |
| 08/02/2001 | WO2001054670A2 Method for coating pharmaceutical dosage forms |
| 08/02/2001 | WO2001054669A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 08/02/2001 | WO2001054668A1 Pharmaceutical compositions comprising a hmg reductase inhibitor |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001054666A1 Liposomes containing an entrapped compound in supersaturated solution |
| 08/02/2001 | WO2001054665A1 Controlled release of drugs |
| 08/02/2001 | WO2001054664A1 A method of administering a medicinal aerosol formulation |
| 08/02/2001 | WO2001054663A2 Surfactant free topical compositions and method for rapid preparation thereof |
| 08/02/2001 | WO2001054662A2 Compressed microparticles for dry injection |
| 08/02/2001 | WO2001054653A1 Galenic formulation |
| 08/02/2001 | WO2001054648A2 Treatment of disorders affecting vigilance related to myopathies |
| 08/02/2001 | WO2001054647A2 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 08/02/2001 | WO2001054636A1 Methods and devices for preventing transmission of sexually transmitted diseases |
| 08/02/2001 | WO2001054514A1 Composition for intestinal delivery |
| 08/02/2001 | WO2001019329A3 Polyoxyalkylene copolymers containing pourable liquid vehicles |
| 08/02/2001 | WO2001015547A3 Active agent preparation for veterinary use and method for the production thereof |
| 08/02/2001 | WO2001013932A3 Stimulation of sperm function |
| 08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 08/02/2001 | WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 08/02/2001 | WO2000069887A3 Rapid dehydration of proteins |
| 08/02/2001 | WO2000064483A3 Releasable linkage and compositions containing same |
| 08/02/2001 | WO2000050349A3 Biodegradable ceramic fibres from silica sols |
| 08/02/2001 | US20010011103 Pure isomers |
| 08/02/2001 | US20010011102 Single-dose antihistamine/decongestant formulations for treating rhinitis |
| 08/02/2001 | US20010011083 Pain reliever and method of use |
| 08/02/2001 | US20010011082 Mixture with chelate compound; bone disorders |
| 08/02/2001 | US20010010826 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from L-arganine analog, dextran, heparin, cysteine and cystine |
| 08/02/2001 | US20010010825 Rapidly disintegrable solid preparation |
| 08/02/2001 | US20010010824 Skin cosmetic comprising in a suitable vehicle, biodegradable polymeric nanomparaticles encapsulating an active oil having cosmeatic and/or pharmaceutical action in the upper layer of epidermis |
| 08/02/2001 | US20010010822 For pharmaceutical preparations |
| 08/02/2001 | DE10038108A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 08/02/2001 | DE10003786A1 Galenische Formulierung Drug formulation |
| 08/02/2001 | DE10003757A1 Ibuprofen-Wirkstoffzubereitung Ibuprofen drug preparation |
| 08/02/2001 | DE10003620A1 Non-aqueous solution or suspension of 5-aminolevulinic acid, is useful in the treatment or diagnosis of tumor diseases or psoriasis by photodynamic therapy |
| 08/02/2001 | DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts |
| 08/02/2001 | CA2423122A1 Closure of bacterial ghosts |
| 08/02/2001 | CA2401590A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 08/02/2001 | CA2401086A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | CA2399229A1 Surfactant free topical compositions and method for rapid preparation thereof |
| 08/02/2001 | CA2398792A1 Auxiliary medicament for ophthalmic operation |
| 08/02/2001 | CA2398788A1 Slow release protein polymers |
| 08/02/2001 | CA2398723A1 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 08/02/2001 | CA2398642A1 Mucin synthesis inhibitors |
| 08/02/2001 | CA2398533A1 Compressed microparticles for dry injection |
| 08/02/2001 | CA2398514A1 Liposomes containing an entrapped compound in supersaturated solution |
| 08/02/2001 | CA2398399A1 Methods and devices for preventing transmission of sexually transmitted diseases |
| 08/02/2001 | CA2398288A1 Ibuprofen containing active agent preparation |
| 08/02/2001 | CA2397755A1 Eye drops containing 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyic acid for the use in the treatment of allergic eye disease |
| 08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | CA2396781A1 A method of administering a medicinal aerosol formulation |
| 08/02/2001 | CA2396711A1 Composition for intestinal delivery |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2396628A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
| 08/01/2001 | EP1120427A1 Method for the formation of low-substituted hydroxypropyl cellulose particles |
| 08/01/2001 | EP1120120A1 Tablets immediately disintegrating in the oral cavity |
| 08/01/2001 | EP1120116A1 Antimycotic drug composition |
| 08/01/2001 | EP1120115A2 Skin-friendly plasters for the transdermal administration of non-steroidal antirheumatic agents |
| 08/01/2001 | EP1120112A2 Wound dressing and drug delivery device |
| 08/01/2001 | EP1120111A1 Tablets and process for producing tablets |
| 08/01/2001 | EP1120110A1 A composition for the preparation of dialytic solutions, a method for the production thereof, and a respective package |
| 08/01/2001 | EP1120109A2 Rapidly disintegrating and fast dissolving solid dosage form |
| 08/01/2001 | EP1120102A2 Nanoemulsion containing amphiphilc lipids and a nonionic polymer and its use in cosmetics |
| 08/01/2001 | EP1120101A2 Nanoemulsion containing amphiphilc lipids and a PEG ester and its use in cosmetics |
| 08/01/2001 | EP1119579A1 Antisense modulation of bcl-x expression |
| 08/01/2001 | EP1119384A2 Flow resistance modulated aerosolized active agent delivery |
| 08/01/2001 | EP1119373A1 Oxybutynin formulations and methods of use |
| 08/01/2001 | EP1119363A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 08/01/2001 | EP1119354A1 Peripherally acting anti-pruritic opiates |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119348A2 Enteric coated pharmaceutical formulation |
| 08/01/2001 | EP1119347A1 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
| 08/01/2001 | EP1119346A2 Rna cancer vaccine and methods for its use |
| 08/01/2001 | EP1119345A1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 08/01/2001 | EP1119335A1 Capsules |